Chronic Obstructive Pulmonary Disease ( Copd )

R.W. appears with progressive difficulty getting his breath while doing simple tasks, and also having difficulty doing any manual work, complains of a cough, fatigue, and weight loss, and has been treated for three respiratory infections a year for the past 3 years. On physical examination, CNP notice clubbing of his fingers, use accessory muscles for respiration, wheezing in the lungs, and hyperresonance on percussion of the lungs, and also pulmonary function studies show an FEV1 of 58%. These all symptoms and history represented here most strongly indicate the probability of chronic obstructive pulmonary disease (COPD). COPD is a respiratory disease categorized by chronic airway inflammation, a decrease in lung function over time, and gradual damage in quality of life (Booker, 2014).

As you already know, Chronic Obstructive Pulmonary Disease (COPD), manifests itself when the passageway of air to the lungs is severely obstructed, thus preventing sufficient flow of oxygen into the bloodstream.1 The pathophysiology of COPD is a complex process that is the result of multiple airway diseases that simultaneously contribute to the impairment of airflow in the lungs.1 Specifically, the overlapping outcome of chronic bronchitis and emphysema is the pathogenesis of COPD.1 The risk factor for the COPD is influenced by the individual’s genetics, age, gender, exposure to air pollution, socioeconomic status, and the use of tobacco products.1 The use of tobacco products can increase the development of COPD.1 However, individuals that don’t smoke can also attain COPD.1 Therefore, COPD is not exclusive to individuals that smoke on a daily basis.1 In fact, genetics and the natural aging process plays a part in the development of pulmonary issues.1 For example, it has been proven that a deficiency in the alpha -1 antitrypsin gene is correlated with the development of COPD.1 The natural deterioration of lung tissue, coupled with the long term exposure to environmental elements, explains why the risk of attaining COPD increases as one progresses to the latter stages of their lives.1 In a healthy individual, goblet cells secrete about one liter of mucous that provides a moist surface over the lungs, trachea, and esophagus.1 The cilia on the pseuodocolumnar epithelial cells continuously sweep the mucus in the lungs in an upward motion.1 The cilia sweeps the mucosal trapped debris up, and removes pathogens and other foreign particles out the pulmonary tissue.1 In individuals with COPD, the pathogenesis of the disease creates structural modifications of the lung tissue, which result in deformed and nonfunctioning cilia.2 The lack of functioning cilia leads to the buildup of mucous, pathogens, and subsequent respiratory infections.2 Furthermore, the body tries to combat

COPD is one of the greatest causes of disability and mortality in the twenty first century with future predictions painting an even graver story. Occupation, genome, and primarily smoking are the main causes of COPD. COPD is the third leading cause of death in America, claiming the lives of 134,676 Americans in 2010. Symptoms are typical of a constant smokers cough which progresses into the debilitating palliative stage of the disease; the development of co-morbidities exacerbates these symptoms. COPD has a complex pathophysiology involving hyperinflation, excessive mucus production and airway remodeling; diagnosis is through lung function tests. COPD is poorly managed with few effective treatments and a poor

Medicines officially utilized as a part of the treatment of COPD may likewise be valuable in some comorbid ailments. New treatments ought to likewise be considered as conceivably helpful to systemic appearances and comorbidities. For instance, a viable breathed in calming treatment may enhance comorbidities by diminishing the overspill of fiery go-betweens from the lung that add to systemic aggravation. On the other hand, an oral calming treatment, and additionally smothering aggravation on the respiratory tract, may straightforwardly decrease systemic irritation. Obviously, a great deal more clinical and essential research is expected to comprehend the unpredictability of COPD so that more successful administration of COPD and its different comorbidities is conceivable later

Intervention for COPD is focused on managing underlying conditions. The goal is to improve airway function. Some strategies include using antibiotics to treat infection, diuretics which reduce pressure on the heart and lungs, some bronchodilators to help expanding the airways, as well as corticosteroids to reduce inflammation, and last in severe cases use of mechanical ventilation can be efficient and effective to keep oxygenation in an optimal level

phrase used to describe respiratory diseases characterized by airway obstruction. COPD is now a well-known and serious chronic disease, killing many and affecting a mass number of people per year. COPD is a result in restricted (obstructed) airflow in the lungs. Obstructive diseases include bronchitis, in which inflammation causes chronic bronchial secretions and narrowing of the bronchi and emphysema a permanent destructive enlargement of the airspaces within the lung.

The most important treatment is to quit smoking, if you are a smoker, and your doctor will assist you with the program that can help you to quit, and avoid other lungs irritants. There are also medications that can help to relieve your symptoms like bronchodilators depending on the severity of your COPD, as there is short acting and long acting bronchodilators. These bronchodilators are used through inhaler which helps to deliver the medicine into your lungs. If your COPD is severe and flare up more often the Pulmonologist (doctor who studies and treats the disease of the lungs) may combine Glucocorticosteroids (steroid) with your bronchodilator inhaler. Diets and exercises also plays major roles in the treatments of COPD, meanwhile, you may be restricted from eating certain foods or eating less, or frequently to prevent symptoms to flare up. Moderate exercise can also be suggested to strengthen the muscle of your lungs and to increase your overall

Serious respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema, are a leading cause of morbidity and death worldwide. Asthma, a chronic disease that involves inflammation of the airways, bronchoconstriction, and intermittent (usually reversible) airflow obstruction, also affects numerous individuals worldwide. Both COPD and asthma are common obstructive lung disorders that affect over 49 million people in the US (1). While the pathology of asthma and COPD are distinct, both diseases share some features. Asthma is often a childhood disease, but some patients manifest symptoms or develop the disease as adults.

The pharmacologic treatment of COPD includes bronchodilators. Medication such Albuterol, levalbuterol, and ipratropium, are bronchodilator that comes in inhalant or liquid form that you add in to nebulizer. These medications relax the muscles around your airways. Anti-inflammatories are also used to help reduce the swelling and mucus production inside the airways. “Drugs used to treat asthma and COPD include drugs to block inflammation and drugs to dilate bronchi”(Karch, 2013, p. 941). Oxygen therapy is use as additional therapy for COPD patients. Managing the exacerbations includes treatment such as antibiotic, because bacterial or viral infection can cause exacerbation. Flu and Pneumococcal vaccination is also recommended to COPD

Chronic Obstructive Pulmonary Disease, also known as COPD, is the third leading cause of death in the United States. COPD includes extensive lungs diseases such as emphysema, non-reversible asthma, specific forms of bronchiectasis, and chronic bronchitis. This disease restricts the flow of air in and out of the lungs. Ways in which these limitations may occur include the loss of elasticity in the air sacs and throughout the airways, the destruction of the walls between air sacs, the inflammation or thickening of airway walls, or the overproduction of mucus in airways which can lead to blockage. Throughout this paper I am going to explain the main causes, symptoms, diagnosis, and ways to reduce COPD.

COPD, or Chronic Obstructive Pulmonary Disease, is one of the most common lung diseases. Thousands of people are diagnosed every year, and it recently moved up to the 3rd leading cause of death in the U.S., behind heart disease and cancer. This paper will discuss disease pathology, the most common and recently discovered diagnostic tests, as well as treatment options. It will also address end of life care.

Unfortunately, there is currently no cure for COPD, but there are medications that are available to help the symptoms and make it easier for the person to breathe. Bronchodilators are a type of medication that will help open the airways to get better airflow. Short acting bronchodilators are used in emergency situations for rapid relief. Some short acting bronchodilators are Albuterol, levalbuterol (Xopenex), and Ipratropium (Atrovent). They can come in an inhaler or in a liquid that can be inhaled from a nebulizer. There are some side effects to the short acting bronchodilators including dry mouth, blurred vision, tremors, tachycardia, or a cough. Long acting bronchodilators help treat the symptoms of COPD over a longer period of time, so it may take longer to see results. Patients can use long acting bronchodilators once or twice a day depended on how bad the symptoms are, which also comes in inhalers or a liquid that can be put in a nebulizer. Some examples of the medication are Tiotropium (Spiriva), Salmeterol (Serevent, Formoterol (Foradil, Perforomist), Arformoterol (Brovana), Indacaterol (Arcapta), Aclidinium (Tudorza). (Mayo Clinic Staff, 2015). Over time these medications will help if the person takes them continually. Long acting Bronchodilators are not used as emergency or rescue medication. Some of the side effects of these medications are dry mouth, dizziness, tremors, runny nose, an irritated or scratchy throat, allergic reactions, blurred vision, and

COPD is an abbreviated term for the lung disease Chronic Obstructive Pulmonary Disease and it is seen in people everyday. It is estimated that this disease affects roughly 24 million individuals in the U.S.. Chronic Obstructive Pulmonary Disease occurs in other countries instead of just the United States. It is increasing rapidly and therapies currently do not alter the disease (Gross “Abstract”). Chronic Obstructive Pulmonary Disease can be caused by smoking, environmental factors and or genetic factors, which are the top three risk factors for this disease (COPD Foundation). Although it can be genetic, it is mostly caused by inhaling pollutants.This disease may be slightly treated if not all the way by different breathing techniques and medications. COPD is a lung disease that worsens as it progresses to the point that it may be life threatening, but it can be prevented by staying away or using caution around pollutants such as harsh fumes and cigarette smoke.

I will analyse the prevalence of the condition and what the potential causes may be. My interests have been directed to pre hospital care and community lead treatment packages, which are potentially available to the patient, as this is the acute environment, which I will have contact with in my employment as a paramedic. The initial reading was to understand COPD as a chronic condition, what is COPD? and its prevalence in the population. The (World health organisation, 2000), states that one in four deaths in the world are caused by COPD. In 2010 (Vos T Flaxman etal, 2012), says globally there were approximately 329 million, which is 4.8% of the population who are affected by this chronic condition, In the UK (NICE, 2010), have estimated that 3 million people suffer from COPD, with more yet to be diagnosed. This information about the amount of people living with this condition was surprising, as I little knowledge of its existence. During the early 1960’s (Timothy Q. Howes, 2005), says the term COPD had been designated as a single term unifying all the chronic respiratory diseases. Since then the term COPD, has been sub divided in to three umbrella areas, Bronchitis, Emphysema and Chronic asthma, which are separate conditions, which I have been previously aware of as their individual conditions. The 58 year old patient who we visited,

All over the world, chronic obstructive pulmonary disease (COPD) is a very significant and prevalent cause of morbidity and mortality, and it is increasing with time (Hurd, 2000; Pauwels, 2000; Petty, 2000). Due to the factor of COPD being an underdiagnosed and undertreated disease, the epidemiology (Pauwels, Rabe, 2004) is about 60 to 85 % with mild or moderate COPD remaining undiagnosed (Miravitlles et al., 2009; Hvidsten et al., 2010).